[1]刘亦杰.跟踪护理对氯吡格雷治疗急性PCI术后患者冠脉再狭窄的预防效果研究[J].医学信息,2023,36(24):155-158.[doi:10.3969/j.issn.1006-1959.2023.24.036]
　LIU Yi-jie.Study on the Preventive Effect of Tracking Nursing on Coronary Restenosis in Patients with Acute PCI After Clopidogrel Treatment[J].Journal of Medical Information,2023,36(24):155-158.[doi:10.3969/j.issn.1006-1959.2023.24.036]
点击复制

跟踪护理对氯吡格雷治疗急性PCI术后患者冠脉再狭窄的预防效果研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年24期
页码:
155-158
栏目:
护理研究
出版日期:
2023-12-15

文章信息/Info

Title:
Study on the Preventive Effect of Tracking Nursing on Coronary Restenosis in Patients with Acute PCI After Clopidogrel Treatment
文章编号:
1006-1959（2023）24-0155-04
作者:
刘亦杰
（天津市胸科医院综合病房，天津 300222）
Author(s):
LIU Yi-jie
(Tianjin Chest Hospital General Ward,Tianjin 300222,China)
关键词:
氯吡格雷; 跟踪护理; 急性PCI术; 冠脉再狭窄
Keywords:
Clopidogrel; Tracking nursing; Acute PCI; Coronary restenosis
分类号:
R473.5
DOI:
10.3969/j.issn.1006-1959.2023.24.036
文献标志码:
A
摘要:
目的 观察氯吡格雷协同跟踪护理对急性PCI术后冠脉再狭窄的预防效果。方法 选取2020年7月-2021年7月在我院诊治的52例急性PCI术后患者为研究对象，采用随机数字表法分为对照组和观察组，各26例。对照组术后给予常规护理，观察组在对照组基础上给予跟踪护理干预，比较两组再狭窄发生率、生活质量水平、并发症发生率、护理满意度、自我管理水平。结果 观察组再狭窄发生率为3.85%，低于对照组的15.38%（P＜0.05）；观察组生活质量各维度评分均高于对照组（P＜0.05）；观察组并发症发生率为7.69%，低于对照组的19.23%（P＜0.05）；观察组护理满意度为96.15%，高于对照组的84.62%（P＜0.05）；观察组定期复查、生活规律、遵医嘱用药、合理饮食、规律运动评分均高于对照组（P＜0.05）。结论 氯吡格雷协同跟踪护理对PCI术后冠脉再狭窄预防具有积极的影响，可有效降低再狭窄、并发症发生率，提高患者生活质量，提升患者自我管理水平，促进和谐关系建立。
Abstract:
Objective To observe the preventive effect of clopidogrel treatment collaborative tracking nursing on coronary restenosis after acute PCI.Methods A total of 52 patients with acute PCI who were treated in our hospital from July 2020 to July 2021 were selected as the research objects. They were divided into control group and observation group by random number table method, with 26 patients in each group. The control group was given routine nursing after operation, and the observation group was given follow-up nursing intervention on the basis of the control group. The incidence of restenosis, quality of life, complication rate, nursing satisfaction and self-management level were compared between the two groups.Results The incidence of restenosis in the observation group was 3.85%, which was lower than 15.38% in the control group (P<0.05). The scores of all dimensions of quality of life in the observation group were higher than those in the control group (P<0.05). The incidence of complications in the observation group was 7.69%, which was lower than 19.23% in the control group (P<0.05). The nursing satisfaction of the observation group was 96.15%, which was higher than 84.62% of the control group (P<0.05). The scores of regular review, regular life, medication according to doctor ’s advice, reasonable diet and regular exercise in the observation group were higher than those in the control group (P<0.05).Conclusion Clopidogrel treatment collaborative tracking nursing has a positive effect on the prevention of coronary restenosis after PCI, which can effectively reduce the incidence of restenosis and complications, improve the quality of life and the self-management level of patients, and promote the establishment of harmonious relationship.

参考文献/References:

[1]郁兴芳.急性心肌梗死患者行急诊PCI术的全程护理[J].医学信息,2016,29(36):175.[2]余晓凤,虞春兰.循证护理对急性心肌梗死并发心律失常患者治疗效果与生活质量的影响[J].护理实践与研究,2019,16(17):51-53.[3]蔡伟英,叶健烽,莫衬南,等.优化护理流程对急性心肌梗死介入时间的影响[J].广东医学,2018,39(15):2396-2398.[4]江彩霞,郭杰文.早期心脏康复策略对急性心肌梗死行经皮冠状动脉介入术后心功能及运动耐力的影响[J].中国实用护理杂志,2020,36(11):818-823.[5]康洪彬.1例急性心肌梗死患者经皮冠状动脉介入术中并发心脏压塞的护理[J].中华护理杂志,2018,53(8):943-994.[6]张穗浩,林峰,董少红.高强度间歇训练在急性心肌梗死介入治疗术后的应用现状[J].中国康复理论与实践,2019,25(6):696-699.[7]罗慧,朱琼瑶,田礼义,等.基于临床护理路径的预防性护理在急性ST段抬高型心肌梗死患者PCI术后康复中的应用[J].齐鲁护理杂志,2020,26(1):62-64.[8]梁茜,张健瑜,杨希立,等.急性冠脉综合征合并糖尿病患者经皮冠脉介入术后替格瑞洛与氯吡格雷的疗效比较[J].中国医科大学学报,2016,45(2):145-149.[9]Kilic S,Fabris E,Van’t Hof AWJ,et al.Thrombus aspiration and prehospital ticagrelor administration in ST-elevation my ocardial infarction: findings from the ATLANTIC trial[J].Am Heart,2018,196(1):1-8.[10]吴学坤,张丽华,郑昕,等.2006年、2011年中国急性ST段抬高型心肌梗死行经皮冠状动脉介入治疗患者负荷剂量氯吡格雷的应用及影响因素[J].中国循环杂志,2016,31(5):432-436.[11]王万虹,张荣林,丁浩,等.替格瑞洛在急性ST段抬高型心肌梗死患者急诊经皮冠状动脉介入治疗中的应用[J].中国心血管杂志,2016,21(1):22-26.[12]马林,胡素玲,李爱玲,等.替格瑞洛在氯吡格雷抵抗急性心肌梗死患者PCI术后抗血小板治疗中的应用价值[J].河北医学,2016,22(3):402-405.[13]刘利峰,赵蓓,时全星,等.经皮冠状动脉介入治疗相关心肌梗死诊断标准研究[J].临床军医杂志,2017,45(6):605-607.[14]郝凌霄,朱广辉,程帅,等.替格瑞洛与氯吡格雷在急性心肌梗死患者经皮冠状动脉介入治疗中有效性和安全性的对比研究[J].实用心脑肺血管病杂志,2017,25(6):50-53.[15]蒋薇薇,黄晶.药物洗脱支架植入术后的双联抗血小板治疗[J].心血管病学进展,2017,38(1):66-69.[16]杨五小,来春林,陈福恒,等.应用Monoclonal技术分析PCI术前使用阿司匹林、氯吡格雷、替格瑞洛对ACS病人血小板功能的影响[J].中西医结合心脑血管病杂志,2017,15(4):453-457.[17]阴淑莹,李爱英,王敏.急性冠脉综合征经皮冠状动脉介入治疗术后替格瑞洛临床疗效分析[J].临床和实验医学杂志,2017,16(19):1937-1940.[18]Lozano I,Rondan J,Vegas JM,et al.Cost effectiveness of long term ticagrelor in patients with prior myocardial infarc tion: Analysis by subgroups[J].Am Coll Cardiol,2018,71(1):107-108.[19]胡永琼,邓云霞,袁彩蓉,等.移动医疗APP及微信群对冠状动脉内支架植入患者感知控制的影响[J].护士进修杂志,2016,31(7):639-642.

相似文献/References:

[1]梁道博,姚卜飞,夏双燕.氯吡格雷联合阿司匹林治疗急性冠脉综合征疗效与 安全性的Meta分析[J].医学信息,2019,32(11):76.[doi:10.3969/j.issn.1006-1959.2019.11.021]
　LIANG Dao-bo,YAO Bu-fei,XIA Shuang-yan.Meta-analysis of the Efficacy and Safety of Clopidogrel Combined with Aspirin in the Treatment of Acute Coronary Syndrome[J].Journal of Medical Information,2019,32(24):76.[doi:10.3969/j.issn.1006-1959.2019.11.021]
[2]王 焕.替格瑞洛在氯吡格雷抵抗AMI患者PCI术后抗血小板治疗中的应用[J].医学信息,2019,32(24):153.[doi:10.3969/j.issn.1006-1959.2019.24.055]
　WANG Huan.Application of Ticagrelor in the Antiplatelet Therapy of Clopidogrel in Patients with AMI after PCI[J].Journal of Medical Information,2019,32(24):153.[doi:10.3969/j.issn.1006-1959.2019.24.055]
[3]刘廷胜.氯吡格雷联合阿司匹林治疗急性心肌梗死的研究[J].医学信息,2020,33(06):59.[doi:10.3969/j.issn.1006-1959.2020.06.018]
　LIU Ting-sheng.A Study of Clopidogrel Combined with Aspirin in the Treatment of Acute Myocardial Infarction[J].Journal of Medical Information,2020,33(24):59.[doi:10.3969/j.issn.1006-1959.2020.06.018]
[4]栾学冰.拜阿斯匹林、那曲肝素联合氯吡格雷治疗急性ST段抬高型心肌梗死疗效[J].医学信息,2020,33(09):136.[doi:10.3969/j.issn.1006-1959.2020.09.043]
　LUAN Xue-bing.The Efficacy of Bayaspirin,Naltreparin Combined with Clopidogrel in the Treatment of Acute ST-segment Elevation Myocardial Infarction[J].Journal of Medical Information,2020,33(24):136.[doi:10.3969/j.issn.1006-1959.2020.09.043]
[5]刘梓良,曹德斌.氯吡格雷联合阿托伐他汀钙治疗缺血性脑卒中患者的疗效及对神经功能的影响[J].医学信息,2021,34(17):111.[doi:10.3969/j.issn.1006-1959.2021.17.028]
　LIU Zi-liang,CAO De-bin.Efficacy of Clopidogrel Combined with Atorvastatin Calcium in the Treatment of Patients with Ischemic Stroke and its Effect on Neurological Function[J].Journal of Medical Information,2021,34(24):111.[doi:10.3969/j.issn.1006-1959.2021.17.028]
[6]张莹莹,郭绪昆,刘 寅.氯吡格雷药代动力学特点及其在心血管疾病中的临床应用[J].医学信息,2021,34(20):45.[doi:10.3969/j.issn.1006-1959.2021.20.011]
　ZHANG Ying-ying,GUO Xu-kun,LIU Yin.Pharmacokinetic Characteristics of Clopidogrel and the Clinical Application in Cardiovascular Diseases[J].Journal of Medical Information,2021,34(24):45.[doi:10.3969/j.issn.1006-1959.2021.20.011]
[7]刘 楠.阿司匹林联合氯吡格雷双抗血小板治疗脑梗死的疗效观察及对血清hs-CRP及D-D水平的影响[J].医学信息,2022,35(19):82.[doi:10.3969/j.issn.1006-1959.2022.19.022]
　LIU Nan.The Effect of Aspirin Combined with Clopidogrel Dual Antiplatelet Therapy on Cerebral Infarction and its Effect on Serum hs-CRP and D-D Levels[J].Journal of Medical Information,2022,35(24):82.[doi:10.3969/j.issn.1006-1959.2022.19.022]
[8]赵东慧.阿替普酶静脉溶栓联合氯吡格雷对急性脑梗死患者脑血流动力学及CRP、Hcy、HDL-C水平的影响[J].医学信息,2022,35(20):74.[doi:10.3969/j.issn.1006-1959.2022.20.018]
　ZHAO Dong-hui.Effect of Alteplase Intravenous Thrombolysis Combined with Clopidogrel on Cerebral Hemodynamics and Levels of CRP, Hcy and HDL-C in Patients with Acute Cerebral Infarction[J].Journal of Medical Information,2022,35(24):74.[doi:10.3969/j.issn.1006-1959.2022.20.018]
[9]曹美娜,刘小平,郑艳安,等.CYP2C19基因型对急性心脑血管梗塞患者预后的影响[J].医学信息,2024,37(03):109.[doi:10.3969/j.issn.1006-1959.2024.03.021]
　CAO Mei-na,LIU Xiao-ping,ZHENG Yan-an,et al.Effect of CYP2C19 Genotype on the Prognosis of Patients with Acute Cardiovascular and Cerebrovascular Infarction[J].Journal of Medical Information,2024,37(24):109.[doi:10.3969/j.issn.1006-1959.2024.03.021]

更新日期/Last Update: 1900-01-01